Peripheral T-cell Lymphoma Market to exhibit a CAGR of 9.46% during the forecast period of 2020 ...

Retrieved on: 2021-02-02 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Peripheral T-cell Lymphoma Market to exhibit a CAGR of 9.46% during the forecast period of 2020 .... View article details on hiswai:

Excerpt

... Acrotech Biopharma); Istodax (Romidepsin, Celgene), Folotyn (Pralatrexate, Acrotech Biopharma), Arranon (Nelarabine, GlaxoSmithKline), and ...

Article found on: finance.yahoo.com